Clinical Trial Update: A Randomized, Controlled Study to Evaluate Algisyl-LVR™ as a Method of Left Ventricular Augmentation for Heart Failure [Phase 2, Phase 3]

View source ↗

Summary

A randomized, controlled study evaluating Algisyl-LVR for left ventricular augmentation in heart failure and dilated cardiomyopathy has completed Phase 2 and Ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dilated Cardiomyopathy
• Heart Failure

Drugs mentioned

• Algisyl-LVR

Snippet

Sponsor: LoneStar Heart, Inc. | Conditions: Heart Failure, Dilated Cardiomyopathy | Phase 2, Phase 3 | Status: COMPLETED